OriGene Logo
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right

Search Results

Your search returned 26 results.
Search:

SKU Category Vector Description Price Delivery
/ CRISPR GFP-puro FXYD2 - human gene knockout kit via CRISPR $1200 4 Weeks
/ CRISPR mBFP-Neo FXYD2 - human gene knockout kit via CRISPR $1290 4 Weeks
/ CRISPR Luciferase-Puro FXYD2 - human gene knockout kit via CRISPR $1290 4 Weeks
/ CRISPR RFP-BSD FXYD2 - human gene knockout kit via CRISPR $1290 4 Weeks
SC322850 Human cDNA pCMV6-Entry FXYD2 (untagged)-Human FXYD domain containing ion transport regulator 2 (FXYD2), transcript variant c NM_001127489.1 $390 2-3 weeks
RC225122 Human ORF PS100001 FXYD2 (Myc-DDK-tagged)-Human FXYD domain containing ion transport regulator 2 (FXYD2), transcript variant c $390 Immediate
RC225122L1 Human ORF PS100064 Lenti ORF clone of Human FXYD domain containing ion transport regulator 2 (FXYD2), transcript variant c , Myc-DDK-tagged $580 Immediate
RC225122L1V Human ORF PS100064 Lenti ORF particles, FXYD2 (Myc-DDK tagged) - Human FXYD domain containing ion transport regulator 2 (FXYD2), transcript variant c , 200ul, >10^7 TU/mL $980 2-3 weeks
RC225122L2 Human ORF PS100071 Lenti ORF clone of Human FXYD domain containing ion transport regulator 2 (FXYD2), transcript variant c, mGFP tagged $640 2-3 weeks
RC225122L2V Human ORF PS100071 Lenti ORF particles, FXYD2 (mGFP-tagged) - Human FXYD domain containing ion transport regulator 2 (FXYD2), transcript variant c, 200ul, >10^7 TU/mL $1080 5-6 weeks
RC225122L3 Human ORF PS100092 Lenti ORF clone of Human FXYD domain containing ion transport regulator 2 (FXYD2), transcript variant c , Myc-DDK-tagged $580 2-3 weeks
RC225122L3V Human ORF PS100092 Lenti ORF particles, FXYD2 (Myc-DDK tagged) - Human FXYD domain containing ion transport regulator 2 (FXYD2), transcript variant c , 200ul, >10^7 TU/mL $980 6-7 weeks
RC225122L4 Human ORF PS100093 Lenti ORF clone of Human FXYD domain containing ion transport regulator 2 (FXYD2), transcript variant c, mGFP tagged $640 3-4 weeks
RC225122L4V Human ORF PS100093 Lenti ORF particles, FXYD2 (mGFP-tagged) - Human FXYD domain containing ion transport regulator 2 (FXYD2), transcript variant c, 200ul, >10^7 TU/mL $1080 6-7 weeks
RG225122 Human ORF PS100010 FXYD2 (GFP-tagged) - Human FXYD domain containing ion transport regulator 2 (FXYD2), transcript variant c $430 2-3 weeks
TF319582 Human shRNA pRFP-C-RS FXYD2 - Human, 4 unique 29mer shRNA constructs in retroviral RFP vector $650 2 Weeks
TG319582 Human shRNA pGFP-V-RS FXYD2 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector $650 2 Weeks
TL319582 Human shRNA pGFP-C-shLenti FXYD2 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector $750 2 Weeks
TL319582V Human shRNA pGFP-C-shLenti FXYD2 - Human shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^6 TU/ml. $1200 5 weeks
TR319582 Human shRNA pRS FXYD2 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector $498 In Stock
/ Human siRNA FXYD2 (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each $300 In Stock
/ Human siRNA FXYD2 (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each $300 2 Weeks
LC426799 Lysate FXYD2 HEK293T cell transient overexpression lysate (as WB positive control) $50 In Stock
LY426799 Lysate LC426799 Transient overexpression lysate of FXYD domain containing ion transport regulator 2 (FXYD2), transcript variant c $280 5 days
/ Mass Spec Standard FXYD2 MS Standard C13 and N15-labeled recombinant protein (NP_001120961) $1500 3 weeks
TP325122 Protein Recombinant protein of human FXYD domain containing ion transport regulator 2 (FXYD2), transcript variant c $680 In Stock
Inc 5000 Healthcare Company
All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title